Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.
André B P van KuilenburgAndrew J WagnerWilliam D TapEmanuela PalmeriniZev A WainbergJayesh DesaiJohn H HealeyMichiel Adreanus van de SandeNicholas M BernthalEric L StaalsCharles G PeterfyAnna Maria FrezzaHenry H HsuQiang WangDale E ShusterSilvia StacchiottiPublished in: Cancer (2020)
This study demonstrates the prolonged efficacy and tolerability of long-term pexidartinib treatment for TGCT.